Pharma Stocks

Latest financials and China pharma exposure

Sinopharm Group Co Ltd, China’s leading pharmaceutical distributor, reported trailing twelve-month revenue of CNY 332.22 billion as of recent data,…

Read More »

Why Milestone Pharmaceuticals Stock Wilted on Wednesday

Not many investors were willing to walk a mile with Milestone Pharmaceuticals (MIST 9.47%) on Hump Day. Shares of the…

Read More »

Morgan Stanley Increases Price Goal on Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 8 Most Promising Biotech Stocks to Buy Now. On May 1, Morgan…

Read More »

Strong Momentum Meets Stretched Valuations as Bliss GVS P…

Price Action and Recent Performance Extending its winning streak to three consecutive sessions, Bliss GVS Pharma Ltd has gained 3.21%…

Read More »

We Think That There Are Some Issues For Ajanta Pharma (NSE:AJANTPHARM) Beyond Its Promising Earnings

The market for Ajanta Pharma Limited’s (NSE:AJANTPHARM) stock was strong after it released a healthy earnings report last week. Despite…

Read More »

Hantavirus Outbreak Sparks Rollercoaster Ride for Biotech Stocks

A localized hantavirus outbreak aboard an Atlantic cruise ship triggered a brief, speculative frenzy in biotechnology stocks this week. Shares…

Read More »

Indian pharma subsidiary eyes growth

Pfizer Ltd, the listed Indian arm of Pfizer Inc., focuses on key therapeutic areas like oncology and vaccines in one…

Read More »

Aurobindo Pharma Ltd stock (INE406A01037): up 0.43% on NSE

Aurobindo Pharma Ltd shares rose 0.43% to 1,485.10 INR on May 8, 2026, amid Indian pharma firms’ $19.1B US expansion…

Read More »

Is Regeneron Pharmaceuticals Among the Best Biotech Stocks to Invest In According to Billionaire Steve Cohen?

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the Best Biotech Stocks. On April 23, Reuters reported that the U.S. Food and Drug…

Read More »

Is It Too Late To Consider Amylyx Pharmaceuticals (AMLX) After A 220% One Year Surge?

If you are wondering whether Amylyx Pharmaceuticals at US$14.73 is still offering value after a strong run, it helps to…

Read More »